Two CHOP Teams Awarded Funds to Study Single Ventricle Congenital Heart Disease
Published on in CHOP News
Two research teams in CHOP’s Cardiac Center have been awarded research grants to study single ventricle congenital heart disease.
Published on in CHOP News
Two research teams in CHOP’s Cardiac Center have been awarded research grants to study single ventricle congenital heart disease.
Published on in CHOP News, Cardiac Center Provider Updates
A recent review in Pediatric Cardiology provides insights into CHOP’s FORWARD program, a multidisciplinary model of care for patients with a Fontan circulation.
Published on in Health Tip of the Week
Coping with the unknowns of COVID-19 can be paralyzing. Get tools to help you and your child better cope and come out stronger.
Published on in CHOP News
Research in the lab and at the bedside offer new hope for young patients with biliary atresia, Alagille syndrome and other chronic liver disorders.
Published on in CHOP News
CHOP researchers found that children with Fontan circulation are slightly shorter than their peers, but further studies are needed to determine whether this effect is long-lasting.
Published on in CHOP News
A new scientific statement from the American Heart Association summarizes the current state of knowledge on Fontan circulation and how best to care for these unique patients.
Published on in CHOP News
Three new clinical research initiatives were selected to receive funding to support their research.
Published on in CHOP News
A recent article in Cardiovascular Business explored the pros and cons of congenital heart disease survivorship clinics across the country.
Published on in CHOP News
Patients who undergo the Fontan operation as children for a complex congenital heart defect are at risk of developing progressive liver fibrosis.
Published on in CHOP News
At Cardiology 2017, an international group of more than 800 medical experts gathered at the nation’s largest pediatric cardiology conference to discuss bringing science into clinical practice to provide optimal care for fetuses, neonates, children and young adults with CHD.